Kyme Pierre bought ARMP
March 9, 2026 · Form 4 insider transaction
Kyme Pierre bought 183,142 shares of Armata Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
183,142
Price
$0.00
Total value
N/A
InsiderKyme Pierre
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after183,142
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the Stock Options shall vest on March 9th of each of 2027, 2028, 2029, and 2030, in each case subject to continuous service through the applicable vesting date.